Raul Silva

Raul Silva

Founder at CINGULATE INC.

Net worth: 24 015 $ as of 2026-08-30

69 year
Health Services
Health Technology
Consumer Services

Profile

Raul R.
Silva
is the founder of Cingulate, Inc., founded in 2012, serving as Chief Science Officer & Executive Vice President since 2018.
Dr. Silva is the founder of Cingulate Works, Inc., founded in 2013, serving as Chief Science Officer & Executive Vice President since 2013.
Dr. Silva currently works at Cingulate Therapeutics LLC as Chief Science Officer.
Former jobs include Vice Chairman at NYU Child Study Center from 2005 to 2009, Director-Child & Adolescent Psychiatry at St. Luke's-Roosevelt Hospital Center from 1994 to 1999, Deputy Director-Child Psychiatry at The Bellevue Hospital from 1999 to 2006, Executive Director at Rockland Children's Psychiatric Center from 2006 to 2009, and Associate Professor at New York University School of Medicine.
Education includes undergraduate studies at Fairleigh Dickinson University and a doctorate from Ross University School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-07-15 4,645 ( 0.03% ) 24 015 $ 2026-08-30

Raul Silva active positions

CompaniesPositionStart
CINGULATE INC. Founder 2012-04-30
Chief Tech/Sci/R&D Officer -
Founder 2012-12-31

Former positions of Raul Silva

CompaniesPositionEnd
Director/Board Member 2008-12-31
Director/Board Member 2008-12-31
Corporate Officer/Principal 2005-12-31
Corporate Officer/Principal 1998-12-31
Corporate Officer/Principal -
See the detail of Raul Silva's experience

Training of Raul Silva

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

22

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Health Technology

Consumer Services

Health Services

Health Services

Health Services

Consumer Services

Consumer Services

Health Technology

Health Services

Health Technology

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!